The Central Drugs Standard Control Organisation (CDSCO) is set to take strict action against Sresan Pharmaceuticals, the manufacturer of Coldrif cough syrup, after several children reportedly died following its consumption, news agency ANI reported.

According to official sources, the CDSCO will write to the Tamil Nadu Food and Drug Administration (FDA), urging stringent measures against the company.

“CDSCO to write to Tamil Nadu-FDA to take strictest action against 'Coldrif' Syrup Manufacturer Sresan Pharmaceuticals,” said the official sources to ANI.

The affected children are from Madhya Pradesh’s Chhindwara, Rajasthan, and Maharashtra, while Kerala and Telangana have issued public alerts banning the use of Coldrif syrup. Another company supplying cough syrups in Madhya Pradesh, Nextro

See Full Page